What Kortex Ventures does

Kortex Ventures is a São Paulo-based Corporate Venture Capital fund that invests exclusively in early-stage healthcare technology companies, deploying capital from seed through Series B across Brazil and Latin America. The fund was established as a joint venture between three of Brazil's largest healthcare incumbents — diagnostic laboratory groups Fleury and Sabin, and health insurer Bradesco Saúde — with a target size of approximately R$200 million (~USD 40 million) and a stated plan to make 15 to 18 investments over a 4-year deployment period.

The fund's core product is growth capital coupled with deep sector-specific value-add: portfolio companies gain access to clinical validation environments, diagnostic laboratory distribution channels, regulatory pathway support, and direct relationships with thousands of physicians, partner hospitals, clinics, and insured patient populations through the founding LPs. Kortex positions itself as an activist investor, providing talent recruitment, go-to-market strategy, fundraising assistance, and long-term ecosystem introductions. The portfolio of 12 disclosed companies spans sleep diagnostics (Biologix), AI-driven imaging and laboratory diagnostics (Neuralmed, Huna), at-home testing and vaccination (SiPhox Health, ISA Lab), occupational health (Welbe), and broader health management platforms.

Economically, Kortex operates as a closed-end managed fund: revenue derives from conventional venture capital mechanisms — management fees on committed/deployed capital and carried interest on successful exits — and the fund does not publicly disclose pricing or fee terms. The firm is qualified as (or in the process of qualifying as) a regulated Brazilian investment manager with CVM and ANBIMA membership, and is led by managing partner Gustavo Cavenaghi with a lean team of 1-10 employees.

Name

Kortex Ventures

Legal name

KX Ventures

Website

https://kortexventures.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Kortex Ventures is a São Paulo-based Corporate Venture Capital fund, backed by Fleury, Sabin, and Bradesco Saúde, that invests from seed to Series B in early-stage healthcare technology companies across Brazil and Latin America, providing portfolio founders with clinical validation, distribution access, and strategic support.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)

Keywords

• Healthcare venture capital
• Corporate venture capital
• Healthtech investments
• Seed to series B funding
• Healthcare innovation fund

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Fund Management: Kortex Ventures generates returns through traditional VC mechanisms including management fees and carried interest (carry) on successful portfolio exits. The fund is structured as a closed-end investment vehicle targeting 15-18 investments over a 4-year deployment period, with capital returned to LPs upon portfolio company exits or acquisitions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Kortex Ventures is a corporate venture capital fund that invests in early-stage healthcare technology companies from seed through Series B. The fund deploys capital and provides strategic support — including talent recruitment, fundraising assistance, and channel development — to healthtech entrepreneurs across Brazil and Latin America. Its portfolio spans diagnostics, AI-driven disease detection, at-home health testing, occupational health, and digital health management platforms.

Product overview

Kortex Ventures is a corporate venture capital fund focused exclusively on healthcare technology investments. The fund is backed by major Brazilian healthcare groups including Fleury, Sabin, and Bradesco Saúde. The fund targets seed to Series B stage companies and acts as activist investors, providing strategic support, talent recruitment, fundraising assistance, and valuable connections to accelerate innovative healthcare businesses. The fund has presence across multiple countries and connections to thousands of doctors, hospitals, clinics and labs.

Differentiator

Problem solved

Functional benefit

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kaszek Ventures: One of the largest LatAm-focused VC firms with active healthcare investments across Brazil, Argentina, and Mexico. Directly comparable as a regional specialist VC operating in Kortex's core geography and stage range.
• Monashees: Brazilian-born multi-stage VC firm with healthcare and life-sciences exposure and a portfolio spanning Brazil and the US. Comparable as a homegrown LatAm generalist with overlapping early-to-growth deal flow similar to Kortex.
• Sanofi Ventures: Corporate venture capital arm of Sanofi focused on early-stage digital health and biopharma. Highly analogous as a healthcare-only CVC backed by a deep-pocketed healthcare incumbent that provides portfolio companies with clinical and commercial channels.
• Roche Venture Fund: Healthcare-focused CVC arm of Roche investing in diagnostics, digital health, and biotech. Directly parallel as a diagnostics-and-healthcare CVC providing clinical validation and channel access to portfolio companies.
• Novartis Venture Fund: CVC arm of Novartis investing in life sciences and digital health across stages. Comparable as a global healthcare CVC deploying the same activist-investor playbook and strategic-LP-backing model that Kortex applies regionally.
• Valor Capital Group: US/Brazil cross-border VC investing in early-to-growth tech companies including healthtech in Brazil and the US. Comparable as a Trans-LatAm VC with healthcare exposure operating in Kortex's geographies.
• ALLVP: Mexico-based early-stage VC firm with healthcare and enterprise focus across LatAm. Comparable as a regional sector-aware VC that often co-invests alongside strategic partners similar to Kortex's LP network.

Emerging players

• Tau Ventures: US-based early-stage VC focused on healthcare AI and digital health. Listed as a Kortex portfolio company but also an independent fund — overlaps with Kortex's portfolio thesis in AI-driven diagnostics and acts as a US-LatAm bridge investor.
• Goodwater Capital: US-based VC with growing healthcare exposure alongside consumer-tech. Adjacent as a sector-specialist VC, though primarily US-focused rather than LatAm-based.

Broad incumbents

• Andreessen Horowitz (a16z Bio/Health): Major US VC with a dedicated Bio/Health fund across digital health, biotech, and care delivery. Comparable as a category-defining healthcare VC but at materially larger AUM and global stage range — illustrates the scale gap Kortex must navigate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kortex Ventures